Lipid Lowering therapy Flashcards

1
Q

Lipid transport

A

Lipoproteins
LDL liver to peripheral tissues, adverse effects
HDL takes lipids from periphery to liver, beneficial
(Triglycerides; adverse vascular effects, pancreatitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why lower cholesterol?

A

Primary prevention: debated, reduction in vascular events

Secondary: Large benefit, after MI for example. Decreases CVS mortality and morbidity. Will reduce vascular events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who to treat with LLT?

A

Secondary prevention: Angina, MI, CVA, PVD
Diabetes (high vascular risk)
Primary prevention: 10 year CV risk score >30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ways to lower cholesterol

A

Drugs and lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drugs to lower lipids

A

Statins: Lower Chol and LDL, slighty raise HDL, and lower trigs. Atorvastatin (more effective) and simvastatin
Fibrates: lower trigs and raise HDL
Ezetimibe: lowerTC and LDL
Nicotinic acid: lower trigs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Statin mechanism of action

when to give

A

1) Inhibit HMG CoA reductase, which normally converts HMG CoA to Mevalonate, eventually cholesterol. (In hepatocytes)
2) Secondary to this, as hepatocytes need cholesterol for bile acids etc, they up regulate LDL receptors, lowering circulating LDL

At night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What else do statins lower? Effect?

A

Isoprenoids, involved with things such as apoptosis.

So called theorised pleiotropic efect, where lowering these can be anti-thrombotic, anti inflammatory and immune modulators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is simvastatin metabolised? Consequence and do no prescribe with?

A

CYP3A4 in the liver P450 system. Atorvastatin not so bad
So do not prescribe with enzyme inhibitors, as prolong effects, increase side effects.
Do not with amiodarone, verapamil, diltiazem, erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Statin side effects

A
Myalgias
Myositis
Rhabdomyolysis
deranged LFT's, stop if ALT 3x normal
Are teratogenic
Very rare, prolonged exposure, new diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

effect on CV risk with statin use according to a meta analysis

A

per mmol/L reduction in LDL

total mortality dow 12% and vascular events down 21%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do fibrates do and indications

Mechansim

A

Lower trigs, lower LDL an raise HDL

  • Isolated triglyceridaemia (lifestyle first) as high triglycerides can induce a pancreatitis
  • Combined with statins with resistant hypercholesterolaemia

Mechanism: PPARalpha agonist. A nuclear receptor that will alter lipid metabolism in liver and muscle, lowering VLDL and increase msucle FA storage. Also activate lipoprotein lipase to break down TG’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrate side effects

A

GI upset, deranged LFT’s, concurrent statin use increases likelihood of myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ezetimibe

A

With statin, lower cholesterol absorption, so less cholesterol delivered to liver, increases LDL receptors in liver, lowers circulating LDL

Blocks NPC1L1 co-transport in enterocyte

Bit of diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotinic acid

A

LowersTrigs synthesis in liver.

reduces FA mobilisation from periphery, reduced HDL degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lipid lowering therapy conclusions

A
  • Secondary prevention definitely statins
  • Primary, lifestyle best, statin use questionable, less than secondary
  • Linear relationship CV events and TGs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PSK9 inhibition

A

Is a circulating serine protease, that is endocytosed with LDL receptor. These will if blocked, decreases LDL

MAB evolocumab
RNA inhibitor inclisiran